{
  "meta": {
    "title": "Adult_Respiratory_Distress_Syndrome",
    "url": "https://brainandscalpel.vercel.app/adult-respiratory-distress-syndrome-028dd651.html",
    "scrapedAt": "2025-11-29T18:32:27.438Z"
  },
  "questions": [
    {
      "id": 14115,
      "choices": [
        {
          "id": 56421,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leukotriene B4 </span></span></span></p>"
        },
        {
          "id": 56422,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor necrosis factor alpha (TNF-&alpha;) </span></span></span></p>"
        },
        {
          "id": 56423,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interleukin-1 (IL-1)</span></span></span></p>"
        },
        {
          "id": 56424,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female presents with fever, cough, and shortness of breath. Her chest X-ray shows bilateral pulmonary infiltrates. Which of the following chemical mediators is most likely involved in the pathogenesis of her acute inflammation?</span></span></p>",
      "unique_key": "Q4467993",
      "question_audio": null,
      "question_video": null,
      "map_id": 31825,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tumor necrosis factor alpha (TNF-&alpha;)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; </strong>is a cytokine that is released by <strong>activated macrophages</strong> and is involved in the <strong>pathogenesis of acute lung injury</strong>. In patients with <strong>acute respiratory distress syndrome (ARDS)</strong>, TNF-&alpha; promotes the<strong> recruitment of neutrophils and other inflammatory cells t</strong>o <strong>the lungs</strong>, leading to the <strong>release of proteases and other enzymes</strong> that contribute to <strong>tissue damage and impaired gas exchange</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNF-&alpha;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a key <strong>pro-inflammatory cytokine </strong>that plays a significant role in <strong>systemic inflammation </strong>and is involved in the pathogenesis of a variety of<strong> inflammatory diseases, </strong>including <strong>acute lung injury and ARDS</strong>. It is released by <strong>activated macrophages and contributes to the recruitment of inflammatory cells</strong>, like <strong>neutrophils,</strong> to the<strong> lung parenchyma,</strong> leading to <strong>increased vascular permeability and pulmonary edema</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Leukotriene B4&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>(LTB4) </strong>is involved in the <strong>inflammatory process</strong>, mainly by attracting <strong>neutrophils to sites of inflammation</strong>. While it is a potent <strong>chemoattractant </strong>and can contribute to<strong> inflammation in the lungs</strong>, it is not the primary mediator in ARDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IL-1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is another important <strong>pro-inflammatory cytokine </strong>and plays a role<strong> similar to TNF-&alpha; in promoting inflammation</strong>. However, it is not as specifically implicated in ARDS as TNF-&alpha;.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Histamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a mediator of<strong> allergic reactions </strong>and contributes to <strong>bronchoconstriction and increased vascular permeability</strong>. While <strong>histamine may</strong> be involved in the early stages of some types of<strong> lung injury</strong>, particularly those with an <strong>allergic or anaphylactic component, </strong>it is not the primary mediator in ARDS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TNF-&alpha; </strong>is a critical mediator in the pathogenesis of <strong>acute lung injury and ARDS</strong>, promoting the <strong>recruitment of inflammatory cells to the lungs </strong>and contributing to the<strong> tissue damage and impaired gas exchange </strong>characteristic of these conditions.</span></span></span></p>",
      "correct_choice_id": 56422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14116,
      "choices": [
        {
          "id": 56425,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factor II (prothrombin) </span></span></span></p>"
        },
        {
          "id": 56426,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factor V (proaccelerin) </span></span></span></p>"
        },
        {
          "id": 56427,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factor VII (proconvertin) </span></span></span></p>"
        },
        {
          "id": 56428,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factor XII (Hageman factor)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old female presents with fever, cough, and shortness of breath. Her chest X-ray shows bilateral pulmonary infiltrates. Which of the following factors in the coagulation cascade is most likely involved in the pathogenesis of her acute inflammation?</span></span></p>",
      "unique_key": "Q6899416",
      "question_audio": null,
      "question_video": null,
      "map_id": 31826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Factor XII (Hageman factor)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Factor XII </strong>is <strong>a serine protease </strong>that plays a critical role in the initiation of the<strong> intrinsic pathway of the coagulation cascade</strong>. In patients with<strong> acute lung injury, activation of the coagulation cascade can </strong>contribute to the pathogenesis of the disease by promoting the formation of <strong>fibrin clots in the pulmonary vasculature and impairing gas exchange</strong>. Factor XII also activates the kallikrein-kinin system, which releases bradykinin, a potent vasodilator that contributes to the inflammatory response.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Factor XII</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, also known as<strong> Hageman factor</strong>, initiates the <strong>intrinsic pathway of coagulation and can activate the fibrinolytic system</strong>. It also<strong> activates the kallikrein-kinin system, </strong>leading to the production of<strong> bradykinin, a mediator that contributes to the inflammatory response</strong>, including <strong>vasodilation and increased vascular permeability</strong>, which are characteristic of acute lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Factor II</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or <strong>prothrombin</strong>, is a <strong>plasma protein </strong>that is converted into <strong>thrombin </strong>in the coagulation cascade. Thrombin is a key enzyme that<strong> converts fibrinogen to fibrin, </strong>leading to <strong>clot formation. </strong>While it is central to the coagulation process, it is not known for initiating the inflammatory response in acute lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Factor V</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>coagulation factor </strong>that works with <strong>factor X to convert prothrombin to thrombin</strong>. It is important in the progression of the coagulation cascade, but again, it is not specifically involved in the initiation of the inflammatory process in lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Factor VII</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is involved in initiating the <strong>extrinsic pathway of the coagulation cascade </strong>upon <strong>tissue injury</strong>. While it is crucial for the<strong> body&#39;s response to vascular injury</strong>, it is not directly involved in the inflammation associated with acute lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of <strong>acute lung injury</strong>, the activation of <strong>Factor XII </strong>can lead to the<strong> formation of fibrin clots in the pulmonary vasculature </strong>and contribute to the <strong>inflammatory response </strong>through the<strong> production of bradykinin. </strong></span></span></span></p>",
      "correct_choice_id": 56428,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14878,
      "choices": [
        {
          "id": 59472,
          "text": "<p><span style=\"font-size:12pt;\">Respiratory distress syndrome</span></p>"
        },
        {
          "id": 59473,
          "text": "<p><span style=\"font-size:12pt;\">Bronchopulmonary dysplasia</span></p>"
        },
        {
          "id": 59474,
          "text": "<p><span style=\"font-size:12pt;\">Sudden infant death syndrome</span></p>"
        },
        {
          "id": 59475,
          "text": "<p><span style=\"font-size:12pt;\">Bronchiolitis obliterans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Hyaline membrane disease is associated with:</span></p>",
      "unique_key": "Q9425360",
      "question_audio": null,
      "question_video": null,
      "map_id": 31830,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Respiratory distress syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Respiratory Distress Syndrome</strong>, also known as<strong> hyaline membrane disease</strong>, primarily affects<strong> premature infants</strong>. It occurs due to a <strong>deficiency of surfactant in the lungs</strong>, leading to difficulty in maintaining<strong> lung expansion </strong>and causing <strong>respiratory distress</strong>. The<strong> hyaline membranes</strong>, composed of<strong> proteins and cellular debris</strong>, form in the <strong>alveoli</strong>, <strong>hindering normal gas exchange</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:&nbsp;Bronchopulmonary Dysplasia (BPD):</strong> Bronchopulmonary dysplasia is a chronic lung disease that can affect premature infants who have received mechanical ventilation and oxygen therapy for respiratory distress. It is characterized by inflammation and scarring in the lungs, leading to long-term respiratory problems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:&nbsp;Sudden Infant Death Syndrome (SIDS):</strong> Sudden Infant Death Syndrome is the<strong> sudden, unexplained death </strong>of an otherwise <strong>healthy infant</strong>, usually during <strong>sleep</strong>. It is <strong>not </strong>directly associated with<strong> hyaline membrane disease </strong>or the other respiratory conditions mentioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:&nbsp;Bronchiolitis Obliterans:</strong> Bronchiolitis obliterans is a condition involving <strong>inflammation and scarring of the small airways (bronchioles) in the lungs</strong>. It can be associated with various causes, including<strong> infections and exposures to certain substances</strong>, but it is<strong> not</strong> specifically associated with <strong>hyaline membrane disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Respiratory Distress Syndrome</strong>, also termed <strong>hyaline membrane disease</strong>, is primarily caused by <strong>surfactant deficiency in premature infants</strong>, leading to the formation of<strong> hyaline membranes </strong>in the<strong> alveoli </strong>and subsequent <strong>respiratory distress.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i><strong>(Ref: Robbins 10<sup>th</sup>/ 460)</strong></i></span></p>",
      "correct_choice_id": 59472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14883,
      "choices": [
        {
          "id": 59492,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0-5%</span></span></p>"
        },
        {
          "id": 59493,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-15% </span></span></p>"
        },
        {
          "id": 59494,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">20-30%</span></span></p>"
        },
        {
          "id": 59495,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30-40%</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The percentage of pulmonary emboli, which proceed to infarction, is approximately:</span></span></span></p>",
      "unique_key": "Q6179580",
      "question_audio": null,
      "question_video": null,
      "map_id": 31824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 5-15%</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pulmonary embolism (PE) </strong>occurs when a <strong>blood clot </strong>or other <strong>material lodges in the pulmonary arteries</strong>, <strong>blocking blood flow </strong>to a <strong>portion of the lung</strong>. <strong>Not all pulmonary emboli lead to infarction</strong>, which is the <strong>death of tissue due to a lack of blood supply. </strong>The likelihood of <strong>infarction depends on various factors</strong>, including the<strong> size and location of the embolus</strong>, the <strong>presence of collateral blood supply, </strong>and the overall health of the individual.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The majority of <strong>pulmonary emboli do not </strong>result in<strong> infarction</strong>, and the <strong>lung tissue </strong>supplied by the<strong> blocked artery </strong>may still <strong>receive enough blood from other vessels (collateral circulation) to prevent infarction.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Robbins direct quote.. &lsquo;Only abou<strong>t 10% of pulmonary artery emboli </strong>actually cause<strong> infarction&rsquo;. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>percentage of pulmonary emboli </strong>that proceed to <strong>infarction </strong>is approximately<strong> 5-15%, </strong>taking into account the fact that the <strong>lung has a dual blood supply</strong>, from<strong> both the bronchial and pulmonary arteries</strong>. This <strong>collateral circulation </strong>often <strong>prevents infarction </strong>by <strong>continuing </strong>to <strong>supply the lung tissue </strong>with blood even<strong> </strong>when the <strong>pulmonary artery is obstructed.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 701) </span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"> </span></span></span></p>",
      "correct_choice_id": 59493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14884,
      "choices": [
        {
          "id": 59496,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lung with pulmonary thromboembolism </span></span></span></p>"
        },
        {
          "id": 59497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart with coronary thrombosis </span></span></span></p>"
        },
        {
          "id": 59498,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver with hypovolemic shock </span></span></span></p>"
        },
        {
          "id": 59499,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kidney with septic embolus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">On sectioning of an organ at the time of autopsy, a focal, wedge-shaped firm area is seen accompanied by extensive hemorrhage, with a red appearance. The lesion has a base on the surface of the organ. This finding is typically of:<em> </em></span></span></span></p>",
      "unique_key": "Q7098355",
      "question_audio": null,
      "question_video": null,
      "map_id": 31827,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Lung with pulmonary thromboembolism </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture3.jpg\" style=\"height:293px; width:400px\" /></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Image of pulmonary infarct (marked by arrow)</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The morphology is characteristically present as<strong> red (hemorrhagic) infarct. </strong>The red infarcts are seen in<strong> lung, liver and intestine</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>White infarcts </strong>are seen in<strong> brain, spleen, kidney and heart.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lung with pulmonary thromboembolism </strong>is characterized by a <strong>wedge-shaped hemorrhagic infarct</strong>. Due to the <strong>dual blood supply from the bronchial and pulmonary arteries</strong>, these infarcts are typically <strong>red (hemorrhagic).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Heart with coronary thrombosis </strong>typically results in<strong> pale (white) infarcts </strong>due to the <strong>loss of blood supply to the myocardium</strong>,<strong> unless reperfusion occurs</strong>, which can lead to a<strong> hemorrhagic appearance</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Liver with hypovolemic shock </strong>may not typically present with a<strong> wedge-shaped lesion </strong>but can show<strong> patchy necrosis </strong>due to <strong>global hypoperfusion</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Kidney with septic embolus </strong>can lead to<strong> infarcts </strong>that are generally<strong> pale (white) due to the organ&#39;s end-arterial blood supply</strong>, except in the case of a<strong> dual blood supply or reperfusion, </strong>which can lead to a<strong> hemorrhagic appearance.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pulmonary thromboembolism </strong>is a condition that can present with a <strong>wedge-shaped, hemorrhagic (red) infarct </strong>on organ sectioning during <strong>autopsy, </strong>with the lesion&#39;s<strong> base on the organ surface.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 135)</span></em></strong></span></span></p>",
      "correct_choice_id": 59496,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14909,
      "choices": [
        {
          "id": 59596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disseminated intravascular coagulation</span></span></span></p>"
        },
        {
          "id": 59597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspiration</span></span></span></p>"
        },
        {
          "id": 59598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Injury to alveolar capillary endothelium</span></span></span></p>"
        },
        {
          "id": 59599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Release of fibrogenic cytokines by macrophages</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year male was operated by hemicolectomy for adenocarcinoma colon. Post surgery he developed respiratory distress and a fall in p02 levels. He was intubated receiving mechanical ventilation with 100% oxygen. X ray chest shows opacity in all lung fields. A transbronchial lung biopsy has the following finding (image as shown). What is the likely mechanism underlying the above-described condition?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/29/picture9.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1262894",
      "question_audio": null,
      "question_video": null,
      "map_id": 31829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Injury to alveolar capillary endothelium</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathology represented above is<strong> adult respiratory distress syndrome (ARDS) </strong>which is characterized by damage to <strong>alveolar capillary membrane </strong>by<strong> neutrophils and macrophages</strong>. Leakage of<strong> proteinaceous fluid </strong>also occurs which <strong>precipitates </strong>as a membrane thus <strong>compromising gaseous exchange</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Aspiration </strong>due to depressed<strong> cough reflex </strong>will lead to <strong>aspiration pneumonia. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;DIC </strong>can complicate<strong> septic shock </strong>but<strong> not a primary cause of ARDS</strong>. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Release of fibrogenic cytokines </strong>causes<strong> diffuse fibrosis </strong>and not membrane deposition. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>injury to the alveolar-capillary endothelium </strong>is the hallmark of <strong>ARDS, </strong>which is characterized by an <strong>acute onset of diffuse pulmonary infiltrates and hypoxemia </strong>following a<strong> precipitating event such as surgery, trauma, or infection</strong>.</span></span></span></p>",
      "correct_choice_id": 59598,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14913,
      "choices": [
        {
          "id": 59612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is deficiency of surfactant produced by type Il alveolar cells</span></span></span></p>"
        },
        {
          "id": 59613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased corticosteroid release lower the risk of developing RDS</span></span></span></p>"
        },
        {
          "id": 59614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with respiratory failure and poor prognosis despite treatment </span></span></span></p>"
        },
        {
          "id": 59615,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">On microscopy, hyaline membranes with fibrin and necrotic cell debris are seen </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infant born to a diabetic mother develops difficulty in breathing within 30 minutes of birth. Within a few hours, cyanosis becomes evident. Fine rales are heard over both lung fields. A chest x-ray film shows ground-glass picture. Which of the following is incorrect about this condition?</span></span></p>",
      "unique_key": "Q6688411",
      "question_audio": null,
      "question_video": null,
      "map_id": 31823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. It is associated with respiratory failure and poor prognosis despite treatment</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with respiratory failure and poor prognosis despite treatment &ndash;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong>. With<strong> current treatments</strong>, including <strong>surfactant replacement and supportive care</strong>, many <strong>infants with RDS survive </strong>and do not have a poor prognosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>There is a deficiency of surfactant produced by type II alveolar cells</strong> &ndash; <strong>Neonatal respiratory distress syndrome (RDS), </strong>also known as<strong> hyaline membrane disease</strong>, is indeed caused by a<strong> lack of surfactant, </strong>which is essential for <strong>decreasing surface tension in the alveoli</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Increased corticosteroid release lowers the risk of developing RDS &ndash;</strong> Corticosteroids stimulate the <strong>production of surfactant </strong>and are given to <strong>at-risk pregnant women </strong>to <strong>reduce the risk of RDS in premature infants.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>On microscopy, hyaline membranes with fibrin and necrotic cell debris are seen &ndash;</strong> Microscopic examination of RDS typically shows hyaline membranes composed of fibrin and cellular debris lining the alveoli.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neonatal respiratory distress syndrome (RDS) </strong>is usually <strong>treatable with current medical interventions</strong>, and with <strong>prompt and appropriate management</strong>, it <strong>does not </strong>have to be associated with <strong>respiratory failure and poor prognosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Robbins 10<sup>th</sup>/ 457</span></span></strong></span></span></span></p>",
      "correct_choice_id": 59614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14860,
      "choices": [
        {
          "id": 59400,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffuse alveolar damage </span></span></span></p>"
        },
        {
          "id": 59401,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial tissue inflammation </span></span></span></p>"
        },
        {
          "id": 59402,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar exudates </span></span></span></p>"
        },
        {
          "id": 59403,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interstitial fibrosis </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the characteristic feature of adult respiratory distress syndrome</span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">?</span></strong></span></span></p>",
      "unique_key": "Q9544794",
      "question_audio": null,
      "question_video": null,
      "map_id": 31828,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Diffuse alveolar damage </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diffuse alveolar damage </strong>is a<strong> hallmark histopathological </strong>finding in <strong>ARDS</strong>. It involves<strong> damage to the walls of the alveoli, </strong>leading to <strong>increased permeability, edema, and impaired gas exchange.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Interstitial tissue inflammation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> </strong>is a characteristic feature of <strong>viral pneumonia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Alveolar exudates</strong>, such as <strong>protein-rich fluid, inflammatory cells, and debris</strong>, are indeed part of the pathology in <strong>ARDS. </strong>The alveoli become filled with these exudates, contributing to<strong> impaired gas exchange</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Interstitial fibrosis </strong>is a <strong>chronic, scarring process. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diffuse alveolar damage </strong>is the <strong>hallmark histopathological finding </strong>in <strong>adult respiratory distress syndrome (ARDS), </strong>characterized by <strong>damage to the alveolar walls</strong>, leading to <strong>increased permeability, pulmonary edema, and consequent impaired gas exchange</strong>.</span></span></p>",
      "correct_choice_id": 59400,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}